# A Study of Prevalence of HER3 Expression in Non-Small Cell Lung Cancer

> **NCT05769764** · — · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 225 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **OTHER:** Archival tissue specimen and immunohistochemistry staining

## Key facts

- **NCT ID:** NCT05769764
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-19
- **Primary completion:** 2023-04-06
- **Final completion:** 2023-04-06
- **Target enrollment:** 225 (ACTUAL)
- **Last updated:** 2023-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05769764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05769764, "A Study of Prevalence of HER3 Expression in Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05769764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*